CNTF and open-angle glaucoma: Another promising approach for continuous intraocular delivery involves the NT-501, an ECT implant meticulously engineered for the sustained and continuous delivery of CNTF directly to the retina [95] for therapy of primary open-angle glaucoma (POAG) [151].